Tumoricidal Activity of Combining the Agonistic DR5 Antibody D-6 With Cisplatin in C30 Cisplatin-Resistant Ovarian Cancer in Vitro and in Vivo

Molecular Medicine Reports - Greece
doi 10.3892/mmr.2014.2193
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Mitigating Cisplatin Resistance in Ovarian Cancer.

English

Transcriptome Profile of OVCAR3 Cisplatin-Resistant Ovarian Cancer Cell Line

BMC Bioinformatics
BiochemistryApplied MathematicsComputer Science ApplicationsStructural BiologyMolecular Biology
2014English

Cisplatin/Carboplatin Cross-Resistance in Ovarian Cancer

British Journal of Cancer
Cancer ResearchOncology
1989English

Liquiritin Induces Apoptosis and Autophagy in Cisplatin (DDP)-resistant Gastric Cancer Cells in Vitro and Xenograft Nude Mice in Vivo

International Journal of Oncology
Cancer ResearchOncology
2017English

Proteomic Analysis of Cisplatin-Resistant Ovarian Concers

2006English

Chemotherapy With Cisplatin: Insights Into Intracellular pH and Metabolic Landscape of Cancer Cells in Vitro and in Vivo

Scientific Reports
Multidisciplinary
2017English

Role of Autophagy in Cisplatin Resistance in Ovarian Cancer Cells

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2014English

Antitumor Activity of Nimotuzumab in Combination With Cisplatin in Lung Cancer Cell Line A549 In�vitro

Oncology Letters
Cancer ResearchOncology
2018English

Cell Growth Inhibitory Effects of Polyphenols With Naphthalene Skeleton Against Cisplatin-Resistant Ovarian Cancer Cells

Applied Biological Chemistry
BiochemistryOrganic ChemistryGeneticsMolecular Biology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy